Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.
The findings show a complex intercontinental transport route for microbes like E. coli, Staphylococcus saprophyticus, and Clostridium difficile, protected from ultraviolet light and dehydration by ...